{"date":"2025-01-17","count":1,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4743-2025-01-17-1738-c5y7tm","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-01-17","time":"17:38:42","subject":"公告本公司FB825應用於治療IgE介導的過敏性疾病之專利取得中國專利證書","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-01-17 17:38，「公告本公司FB825應用於治療IgE介導的過敏性疾病之專利取得中國專利證書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}